Drugs / MenAC conjugate vaccine
last change May 2026 re-read 2 minutes ago

MenAC conjugate vaccine

Developed for
meningococcal infection

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT07135986 Comparator Sep 2025 → May 2026 overdue meningococcal infection Sanofi Active not recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MenAC conjugate vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT07135986